Mission Core Values
Rapid HIV Tests H. Pylori Multiple Tests Research Tools Quality Commitment
Core Technology Features & Functionality IP Estate
Media Resources Media Contacts
Distributors & Partners

Helping People Know

Diagnostics Products


multiMED markets and sells quality rapid diagnostics that help healthcare providers, public health agencies, and individuals prevent and control the spread of infectious diseases like HIV and Hepatitis.

One test, one specimen, one result in 3 minutes

Our products use MedMira's patented Rapid Flow Technology, a world class rapid diagnostics platform which enables the world's fastest rapid HIV test.

Welcome to multiMED Holdings Group, Inc.

multiMED Holdings Group, Inc., is a North American based medical biotechnology company with a corporate office in Richmond, Virginia.

The global market for in-vitro diagnostics (IVD) has been estimated by independent research groups to be in the region of $38 billion with the expectation of annual growth to be around 9%. With the diagnosis of patients representing on average 6% of total costs within a nation’s healthcare system, while directly influencing over 60% of total costs, the use of rapid tests provides an accurate and cost effective alternative to screening to obtain early diagnosis to facilitate both treatment and prevention of many diseases.

Rapid tests symbolize a key part to sustainable health solutions for the developing as well as the developed world’s fight against the spread of diseases whilst significantly reducing health care expenditures.

Product Benefits

Most advanced rapid diagnostics

FDA CE and China approved

Instant results

Easy for mass testing

Single & multiple disease tests

Patented Technology

Decreased costs

A safer world!